The New Jersey Innovation Institute (NJII) and New York healthcare IT firm Cognome are working together to transform patient care with AI and machine learning (ML).

This partnership leverages Cognome’s ethical AI tools, developed at two academic healthcare systems, with NJII’s professional services to deliver clinical intelligence, operational efficiencies and outcomes improvement. Healthcare Innovation Solutions (HCIS), the quality and performance improvement subsidiary of NJII, will bring these AI innovations to market.

“We are thrilled to partner with Cognome to advance AI and machine learning in healthcare,” said Jennifer D’Angelo, CEO of HCIS. “By aligning stakeholder initiatives, we can ensure all hospitals and providers benefit from AI-driven innovation, enhancing research, patient care, safety and operations.”

NJII, an NJIT corporation, is dedicated to accelerating healthcare technology and fostering innovation throughout New Jersey and beyond. Cognome, formed through a joint venture between Montefiore Health System and the University of Texas at Houston, offers AI and machine-learning models, as well as the AI governance platform, ExplainerAI, purpose-built for healthcare.

“This partnership aligns with our commitment to accelerate innovation in key sectors such as healthcare,” said Tom Villani, NJII vice president. “All of our AI models integrate seamlessly with EHRs, delivering real-time insights to physicians. The sepsis reduction model has demonstrated the lowest flag rate in the industry. AutoChart AI reduces manual chart abstraction by over 90%, providing significant RoI through operational efficiencies and prospective attribution.”

The ExplainerAI platform, built on the NIH AI governance framework, enhances trustworthiness and transparency while reducing bias through responsible AI models, crucial for clinician adoption. It also aligns with NIST’s AI Risk Management Framework addressing the need for proper privacy, auditability, cyber security and compliance for AI models including those from third parties.

“Partnering with NJII combines our 15 years of building proven AI and ML capabilities with their deep knowledge and collaboration throughout NJ’s healthcare ecosystem,” said James Green, Cognome CEO. “Size and diversity in patient data are the fuel for intelligent, accurate and responsible AI models.”

The partnership will bring together healthcare delivery stakeholders including researchers, technology leaders, AI and ML practitioners, and operational and quality teams to collaborate on high-value use cases. NJII will also provide data science expertise and custom model development services to meet the growing demand for analytics and purpose-built AI.

To learn more about this partnership, focused on delivering high-value operational and clinical use cases, there is a webinar on April 29th, see www.njii.com/events/accelerating-ai-adoption-in-nj-healthcare-collaboration-real-world-impact.

NJII (www.njii.com), a non-profit subsidiary of NJIT, turns ideas into workable options in healthcare, partnerships, defence and education. NJII combines NJIT’s resources and industry ties to drive innovation that impacts the economy and public welfare. HCIS (healthcareinnovationsolutions.com), a wholly owned subsidiary of NJII, provides quality and performance improvement that helps providers with population health and value-based care programmes.

With 15 years of R&D, seven patents and real-time AI and ML models deployed across 20 hospitals, Cognome (cognome.com) is showing how healthcare data can transform care delivery, clinical operations and medical research.